Taoka Chemical Company, Limited (TYO:4113)
697.00
-12.00 (-1.69%)
Jun 4, 2026, 11:30 AM JST
Taoka Chemical Company Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,387 | 1,182 | 972 | 853 | 718 |
Short-Term Investments | 1,550 | 1,800 | - | - | - |
Cash & Short-Term Investments | 2,937 | 2,982 | 972 | 853 | 718 |
Cash Growth | -1.51% | 206.79% | 13.95% | 18.80% | -83.42% |
Receivables | 6,156 | 5,590 | 5,519 | 4,436 | 6,068 |
Inventory | 7,924 | 7,339 | 8,405 | 10,653 | 10,035 |
Other Current Assets | 343 | 315 | 270 | 302 | 1,016 |
Total Current Assets | 17,360 | 16,226 | 15,166 | 16,244 | 17,837 |
Property, Plant & Equipment | 12,317 | 12,957 | 13,310 | 13,533 | 13,236 |
Long-Term Investments | 250 | 227 | 238 | 201 | 194 |
Other Intangible Assets | 79 | 40 | 48 | 54 | 60 |
Long-Term Deferred Tax Assets | 922 | 958 | 955 | 1,035 | 1,089 |
Other Long-Term Assets | - | -1 | 2 | 2 | 1 |
Total Assets | 30,928 | 30,407 | 29,719 | 31,069 | 32,417 |
Accounts Payable | 5,241 | 4,951 | 4,320 | 4,155 | 6,641 |
Accrued Expenses | 494 | 511 | 463 | 503 | 508 |
Short-Term Debt | - | - | 100 | 1,600 | 8 |
Current Portion of Long-Term Debt | 620 | 620 | 620 | 620 | 320 |
Current Income Taxes Payable | 312 | 412 | 212 | 40 | 189 |
Other Current Liabilities | 1,967 | 1,788 | 2,563 | 2,716 | 4,496 |
Total Current Liabilities | 8,634 | 8,282 | 8,278 | 9,634 | 12,162 |
Long-Term Debt | 250 | 870 | 1,490 | 2,110 | 480 |
Pension & Post-Retirement Benefits | 2,194 | 2,433 | 2,519 | 2,524 | 2,627 |
Other Long-Term Liabilities | 300 | 322 | 222 | 231 | 400 |
Total Liabilities | 11,378 | 11,907 | 12,509 | 14,499 | 15,669 |
Common Stock | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
Additional Paid-In Capital | 1,009 | 1,009 | 1,008 | 1,008 | 1,008 |
Retained Earnings | 16,634 | 15,673 | 14,452 | 13,890 | 14,095 |
Treasury Stock | -40 | -40 | -39 | -39 | -39 |
Comprehensive Income & Other | 375 | 286 | 217 | 139 | 112 |
Shareholders' Equity | 19,550 | 18,500 | 17,210 | 16,570 | 16,748 |
Total Liabilities & Equity | 30,928 | 30,407 | 29,719 | 31,069 | 32,417 |
Total Debt | 870 | 1,490 | 2,210 | 4,330 | 808 |
Net Cash (Debt) | 2,067 | 1,492 | -1,238 | -3,477 | -90 |
Net Cash Growth | 38.54% | - | - | - | - |
Net Cash Per Share | 144.26 | 104.12 | -86.40 | -242.67 | -6.28 |
Filing Date Shares Outstanding | 14.33 | 14.33 | 14.33 | 14.33 | 14.33 |
Total Common Shares Outstanding | 14.33 | 14.33 | 14.33 | 14.33 | 14.33 |
Working Capital | 8,726 | 7,944 | 6,888 | 6,610 | 5,675 |
Book Value Per Share | 1364.40 | 1291.11 | 1201.08 | 1156.41 | 1168.83 |
Tangible Book Value | 19,471 | 18,460 | 17,162 | 16,516 | 16,688 |
Tangible Book Value Per Share | 1358.89 | 1288.32 | 1197.73 | 1152.64 | 1164.64 |
Order Backlog | - | 27 | 43.84 | 27.82 | 24.52 |